Organto Foods Announces Fiscal 2024 Financial Results
Organto Foods (OGOFF) reported its fiscal 2024 financial results, showing significant growth with sales reaching $20.7 million, a 48% increase from the previous year's $14.0 million. The company's fourth quarter demonstrated strong momentum with sales of $6.5 million, up 107% year-over-year.
The company achieved a gross profit of $1.8 million (8.5% margin) for the full year, and $0.6 million (9.1% margin) in Q4. Notable events include the sale of three operating subsidiaries in June 2024, resulting in a $2.6 million gain. The company reported a net loss of $2.0 million for 2024, significantly improved from the $13.4 million loss in 2023.
The restructuring efforts included streamlining the product portfolio, refocusing market strategies, and reducing costs through internal reorganization. The company completed a private placement and shares for debt settlements, with convertible debentures expected to convert to equity.
Organto Foods (OGOFF) ha comunicato i risultati finanziari per l'esercizio 2024, evidenziando una crescita significativa con vendite pari a 20,7 milioni di dollari, un aumento del 48% rispetto ai 14,0 milioni dell'anno precedente. Il quarto trimestre ha mostrato un forte slancio con vendite di 6,5 milioni di dollari, in crescita del 107% su base annua.
L'azienda ha registrato un utile lordo di 1,8 milioni di dollari (margine dell'8,5%) per l'intero anno e 0,6 milioni di dollari (margine del 9,1%) nel quarto trimestre. Tra gli eventi rilevanti, la vendita di tre filiali operative a giugno 2024, che ha generato un guadagno di 2,6 milioni di dollari. Il risultato netto dell'anno è stato una perdita di 2,0 milioni di dollari, in netto miglioramento rispetto ai 13,4 milioni di perdita del 2023.
Le iniziative di ristrutturazione hanno incluso la razionalizzazione del portafoglio prodotti, il riposizionamento delle strategie di mercato e la riduzione dei costi tramite una riorganizzazione interna. L'azienda ha completato un collocamento privato e la conversione di azioni per il saldo di debiti, con obbligazioni convertibili destinate a trasformarsi in capitale azionario.
Organto Foods (OGOFF) presentó sus resultados financieros del año fiscal 2024, mostrando un crecimiento significativo con ventas que alcanzaron los 20,7 millones de dólares, un aumento del 48% respecto a los 14,0 millones del año anterior. El cuarto trimestre mostró un fuerte impulso con ventas de 6,5 millones de dólares, un incremento del 107% interanual.
La compañía logró un beneficio bruto de 1,8 millones de dólares (margen del 8,5%) en todo el año, y de 0,6 millones de dólares (margen del 9,1%) en el cuarto trimestre. Entre los eventos destacados está la venta de tres filiales operativas en junio de 2024, que generó una ganancia de 2,6 millones de dólares. La empresa reportó una pérdida neta de 2,0 millones de dólares en 2024, una mejora considerable respecto a la pérdida de 13,4 millones en 2023.
Las acciones de reestructuración incluyeron la simplificación del portafolio de productos, el reenfoque de las estrategias de mercado y la reducción de costos mediante una reorganización interna. La empresa completó una colocación privada y acciones para el pago de deudas, con bonos convertibles que se espera se conviertan en capital.
Organto Foods (OGOFF)는 2024 회계연도 재무 실적을 발표하며 매출이 2,070만 달러로 전년 1,400만 달러 대비 48% 증가한 눈에 띄는 성장을 보였습니다. 4분기 매출은 650만 달러로 전년 동기 대비 107% 상승하며 강한 모멘텀을 나타냈습니다.
회사는 연간 매출총이익 180만 달러(8.5% 마진)와 4분기 매출총이익 60만 달러(9.1% 마진)를 기록했습니다. 주요 사건으로는 2024년 6월에 세 개의 운영 자회사를 매각해 260만 달러의 이익을 실현한 점이 있습니다. 2024년 순손실은 200만 달러로 2023년 1,340만 달러 손실에서 크게 개선되었습니다.
구조조정 노력으로 제품 포트폴리오 간소화, 시장 전략 재조정, 내부 조직 개편을 통한 비용 절감이 포함되었습니다. 회사는 사모 발행과 부채 상환을 위한 주식 발행을 완료했으며, 전환사채는 주식으로 전환될 예정입니다.
Organto Foods (OGOFF) a publié ses résultats financiers pour l'exercice 2024, affichant une croissance significative avec des ventes atteignant 20,7 millions de dollars, soit une augmentation de 48 % par rapport aux 14,0 millions de l'année précédente. Le quatrième trimestre a montré un fort élan avec des ventes de 6,5 millions de dollars, en hausse de 107 % sur un an.
L'entreprise a réalisé un bénéfice brut de 1,8 million de dollars (marge de 8,5 %) sur l'année complète, et de 0,6 million de dollars (marge de 9,1 %) au quatrième trimestre. Parmi les événements marquants, la vente de trois filiales opérationnelles en juin 2024, générant un gain de 2,6 millions de dollars. La société a enregistré une perte nette de 2,0 millions de dollars en 2024, une nette amélioration par rapport à la perte de 13,4 millions en 2023.
Les efforts de restructuration ont inclus la rationalisation du portefeuille de produits, le recentrage des stratégies de marché et la réduction des coûts via une réorganisation interne. L'entreprise a finalisé un placement privé et des actions pour le règlement de dettes, les obligations convertibles devant être converties en actions.
Organto Foods (OGOFF) meldete seine Finanzergebnisse für das Geschäftsjahr 2024 und verzeichnete ein erhebliches Wachstum mit einem Umsatz von 20,7 Millionen US-Dollar, was einer Steigerung von 48 % gegenüber 14,0 Millionen im Vorjahr entspricht. Das vierte Quartal zeigte eine starke Dynamik mit einem Umsatz von 6,5 Millionen US-Dollar, was einem Anstieg von 107 % im Jahresvergleich entspricht.
Das Unternehmen erzielte einen Bruttogewinn von 1,8 Millionen US-Dollar (8,5 % Marge) für das Gesamtjahr und 0,6 Millionen US-Dollar (9,1 % Marge) im vierten Quartal. Zu den bemerkenswerten Ereignissen zählt der Verkauf von drei operativen Tochtergesellschaften im Juni 2024, der einen Gewinn von 2,6 Millionen US-Dollar einbrachte. Für 2024 wurde ein Nettoverlust von 2,0 Millionen US-Dollar gemeldet, was eine deutliche Verbesserung gegenüber dem Verlust von 13,4 Millionen im Jahr 2023 darstellt.
Die Umstrukturierungsmaßnahmen umfassten die Straffung des Produktportfolios, die Neuausrichtung der Marktstrategien und Kostensenkungen durch interne Reorganisation. Das Unternehmen schloss eine Privatplatzierung sowie Aktientransaktionen zur Schuldentilgung ab, wobei wandelbare Schuldverschreibungen voraussichtlich in Eigenkapital umgewandelt werden.
- 48% year-over-year revenue growth to $20.7 million
- Q4 sales grew 107% year-over-year to $6.5 million
- 35% increase in gross profit to $1.8 million
- $2.6 million gain from sale of subsidiaries
- Significant reduction in net loss from $13.4M to $2.0M
- Operating loss increased to $2.4M from $1.7M previous year
- Gross margin declined to 8.5% from 9.3% previous year
- Operating expenses increased to $3.3M from $2.3M
- Continued net loss position of $2.0M
Fourth Quarter 2024 Results Demonstrate Building Momentum in Business
TORONTO, ON AND BREDA, THE NETHERLANDS / ACCESS Newswire / April 28, 2025 / Organto Foods Inc. (TSX-V:OGO)(OTCQB:OGOFF)(FSE:OGF) ("Organto" or "the Company"), is pleased to announce its audited financial results for the year ended December 31, 2024. All amounts are expressed in Canadian dollars and in accordance with International Financial Reporting Standards (IFRS), except where specifically noted.
"2024 was a year of significant restructuring and realignment for our Company as we positioned our business for sustained growth and stability, and a clear path to profitability. We have made excellent progress with these goals by streamlining our product portfolio, refocusing our go-to-market strategies and reducing costs via both ongoing internal reorganization and the sale of three operating subsidiaries. As we entered the back half of 2024, the performance of our business has accelerated, with strong sales and gross margin growth being realized on a streamlined cost base. These accomplishments have propelled us into 2025 where we continue to see strong positive momentum with a focus on positive cash flow. When combined with the recent completion of our private placement and shares for debt settlements, and the expected conversion of our outstanding convertible debentures to equity in the coming days, we are very excited by our future prospects. We remain intently committed to building a world-class foods company serving growing healthy foods markets, with the goal of creating long-term value for our operating partners, customers, team members and shareholders. We appreciate the support and understanding we have received from so many of our shareholders, debenture holders and key operating partners and are most confident that we are well positioned for a successful future."
Fiscal 2024 Results Overview
Fiscal 2024 sales of
$20.7 million versus$14.0 million in the prior year, an increase of approximately48% . Sales have increased throughout the year as new business has been on-boarded and existing customers have expanded their sales over the course of the year. Q-4 sales were the largest quarterly sales of the year and largest ever for our restructured operations post our sale of subsidiaries in June 2024.Gross profit of
$1.8 million or8.5% of sales, versus$1.3 million or9.3% of sales in the prior year, an increase of approximately35% in gross profit dollars. Adjusted gross profit(1) of$1.8 million or8.6% when accounting for the impact of realized gains on derivatives versus8.4% in the prior year.Cash operating expenses of
$3.3 million or15.8% of sales versus$2.3 million or16.6% of sales in the prior year. Operating expenses have stabilized following the sale of the subsidiaries in Q-2 2024 and reflect the increased costs of operating that were previously borne by the sold subsidiaries. YTD costs include approximately$217,000 of legal and listing fees related to restructuring and re-listing activities and a one-time management fee bonus accrual of$246,600 related to past services.Loss from operations of
$2.4 million versus a loss of 1.7 million in the prior year. Loss from operations in 2024 includes one-time non-cash stock-based compensation of$0.6 million and management fee bonuses and restructuring costs of$0.5 million .Adjusted loss from operations of
$1.3 million versus$1.8 million in the prior year when adjusted for one-time cash stock compensation expense, management fees, restructuring costs and realized gains/losses on derivatives.Net loss from continuing operations of
$3.3 million versus a loss in the prior year of$5.6 million driven by improved operating earnings, as well as decreased interest and accretion costs as convertible debentures were already accreted to face value in 2023 for the majority ($9.6 million of the total$10.6 million ) of the debentures offset by one-time stock based compensation costs of$0.6 million and costs related to restructuring of$0.5 million .Gain on dissolution of subsidiary of
$0.4 million related to the wind-up of our Argentina subsidiary.Gain on sale of subsidiaries of
$2.6 million related to the sale of Organto Europe BV, BeeOrganic BV and Fresh Organic Choice BV in June 2024.Net loss including discontinued operations of
$2.0 million in 2024 versus a net loss including discontinued operations of$13.4 million in 2023.
Fourth Quarter 2024 Results Overview
Sales of approximately
$6.5 million versus$3.1 million in the prior year, an increase of approximately107% . Average monthly sales in Q-4 2025 of$2.15 million versus average monthly sales in Q-3 2024 of$1.74 million , an increase of approximately24% versus the Q-3 average, with the increase driven primarily by increased sales of bananas and despite ongoing liquidity challenges. Q-4 sales are the largest quarterly sales of the year and largest ever for our restructured operations post our sale of subsidiaries in June 2024.Gross profit dollars of
$0.6 million or9.1% of sales, versus$0.3 million or9.1% of sales in the prior year, an increase of107% in gross profit dollars. Gross profit dollars represent the largest quarterly gross profit dollars ever for our restructured operations post the sale of subsidiaries in June 2024. Adjusted gross profit(1) of$0.7 million or10.7% when accounting for the impact of realized gains on derivatives versus8.2% in the prior year.Cash operating expenses of
$1.2 million or19.3% of sales versus$0.8 million or24.2% of sales in the prior year. Operating expenses have now stabilized following the sale of the subsidiaries and now include operating costs that were previously included in the results of the subsidiaries that were sold. Q-4 cash operating costs include approximately$108,000 of legal and listing fees related to restructuring and re-listing activities and a one-time management fee bonus accrual of$246,600 related to past services.Loss from operations of
$1.3 million versus$0.6 million in the prior year. Adjusted loss from operations of$0.3 million when adjusted for realized gain on derivatives, one time stock-based compensation and management fees and the costs of restructuring versus a loss of$0.6 million in the prior year when adjusted for a realized loss on derivatives).Net loss for the quarter, including discontinued operations, was
$1.7 million versus$7.5 million in the prior year.
The Company's filings including Audited Financial Statements and accompanying Management's Discussion and Analysis for the year ended December 31, 2024 at www.SEDARplus.ca or at the Company's website at www.organto.com under the Investors tab.
ON BEHALF OF THE BOARD,
Steve Bromley
Chair and Chief Executive Officer
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.
For more information contact:
Investor Relations
info@organto.com
John Rathwell, Senior Vice President, Corporate Development and Investor Relations
647 629 0018
The information presented herein refers to the non-IFRS financial measure of adjusted gross profit. We hedge currencies for certain product categories where either the supply or sales commitments are fixed in foreign currencies. The gains and losses from these hedging activities are combined with gross profit to determine adjusted gross profit. This measure is not a recognized measure under IFRS and does not have a standardized meaning prescribed by IFRS. Non-IFRS financial measures should not be considered in isolation nor as a substitute for analysis of the Company's financial information reported under IFRS and are unlikely to be comparable to similar measures presented by other issuers. Rather, these measures are provided as additional information to complement those IFRS measures by providing further understanding of the Company's results of operations from management's perspective and thus highlight trends in its business that may not otherwise be apparent when relying solely on IFRS measures. The Company believes that securities analysts, investors and other interested parties frequently use non-IFRS financial measures in the evaluation of the Company. The Company's management also uses non-IFRS financial measures to facilitate operating performance comparisons from period to period and to prepare annual operating budgets and forecasts.
ABOUT ORGANTO
Organto is an integrated provider of branded, private label, and distributed organic and non-GMO fruit and vegetable products using a strategic asset-light business model to serve a growing socially responsible and health-conscious consumer around the globe. Organto's business model is rooted in its commitment to sustainable business practices focused on environmental responsibility and a commitment to the communities where it operates, its people, and its shareholders.
FORWARD LOOKING STATEMENTS
This news release may include certain forward-looking information and statements, as defined by law including without limitation Canadian securities laws and the "safe harbor" provisions of the US Private Securities Litigation Reform Act of 1995 ("forward-looking statements"). In particular, and without limitation, this news release contains forward-looking statements respecting Organto's business model and markets; Organto's belief that the while there is still work to be done, the Company has made solid progress in the restructuring and realignment of its business focused on a clear path to profitability, sustained growth and long-term stability; Organto's belief that the impact of these restructuring efforts are will continue to become apparent in the financial results of the Company; Organto's belief that the combination of financing and debt restructuring efforts combined with strong sales and margin growth on a streamlined cost base positions the Company for an exciting future; Organto's belief that it remains focused on building a world class company focused on growing healthy foods markets with the gaol of building shareholder value; management's beliefs, assumptions and expectations; and general business and economic conditions. Forward-looking statements are based on a number of assumptions that may prove to be incorrect, including without limitation assumptions about the following: the ability and time frame within which Organto's business model will be implemented and product supply will be increased; cost increases; dependence on suppliers, partners, and contractual counter-parties; changes in the business or prospects of Organto; unforeseen circumstances; risks associated with the organic produce business generally, including inclement weather, unfavorable growing conditions, low crop yields, variations in crop quality, spoilage, import and export laws, and similar risks; transportation costs and risks; general business and economic conditions; and ongoing relations with distributors, customers, employees, suppliers, consultants, contractors, and partners. The foregoing list is not exhaustive and Organto undertakes no obligation to update any of the foregoing except as required by law.
SOURCE: Organto Foods, Inc.
View the original press release on ACCESS Newswire
FAQ
What was Organto Foods (OGOFF) revenue growth in fiscal 2024?
How did Organto's Q4 2024 performance compare to previous quarters?
What was the impact of Organto's subsidiary sales in 2024?
How much did Organto Foods (OGOFF) reduce its net loss in 2024?
